Description
A 44-Amino-Acid GHRH(1-44) Analog for Endocrine Research
Tesamorelin is a synthetic 44-amino-acid analog of growth hormone-releasing hormone (GHRH 1-44), modified with an N-terminal trans-3-hexenoic acid group for extended stability. Its FDA-approved pharmaceutical form (Egrifta) is a prescription-only drug for a narrow indication. Amino Architects supplies Tesamorelin strictly as a lyophilized reference compound for laboratory research; it is not offered as a substitute for, or equivalent to, any prescription drug product.
Molecular Profile
- Compound: Tesamorelin (GHRH 1-44 analog)
- Dosage: 5mg lyophilized peptide per vial
- Purity: ≥99.7%, TFA-free
- Form: Sterile lyophilized powder for reconstitution
Research Background
Tesamorelin binds GHRH receptors on pituitary somatotrophs, and its receptor pharmacology is well characterized in endocrinology literature studying the growth hormone / IGF-1 axis. It is used in research settings as a reference GHRH-receptor agonist.
Storage & Handling
- Store lyophilized powder at or below -4°F prior to reconstitution
- Refrigerate at 36–46°F after reconstitution with bacteriostatic water
- For laboratory research use only. Not for human consumption.
Reviews
There are no reviews yet.